Merck Manual

Please confirm that you are a health care professional

honeypot link

Drug-Induced Autoimmunity


Jennifer M. Barker

, MD, Children's Hospital Colorado, Division of Pediatric Endocrinology

Last full review/revision Jun 2019| Content last modified Jun 2019
Click here for Patient Education

Patients receiving drugs in the novel class of cancer therapeutics called immune checkpoint inhibitors, have an increased risk for development of autoimmune disorders, including endocrine disorders. Hypophysitis, autoimmune thyroid disease (both hyper and hypothyroidism), type 1 diabetes, and primary adrenal insufficiency have been reported (1).

Diagnosis is by measurement of levels of glucose, electrolytes, and hormones as clinically indicated.

Treatment is replacement of hormones documented to be deficient. These might include thyroid hormone, insulin, or glucocorticoids.

General reference

  • 1. Ruggeri RM, Campennì A, Giuffrida G, et al: Endocrine and metabolic adverse effects of immune checkpoint inhibitors: an overview (what endocrinologists should know). J Endocrinol Invest Nov. 23, 2018.

Click here for Patient Education
NOTE: This is the Professional Version. CONSUMERS: Click here for the Consumer Version
Professionals also read

Also of Interest